Skip to content
Menu

Polyrizon Ltd. PLRZ

Full chart Compare
Set alert

Price alert · PLRZ

All alert types
11.05 USD 0.00 (+0.00%)

Regular-session close

10.90 -0.15 -1.36%

After hours · Nov 13, 4:00 PM ET

Day range unavailable

2.88 52-week range 18.20
YTD
+30.15%
1 year
+139.18%
Market cap
26.84M
EPS (ttm)
-4.97
Shares out
4.19M
YTD return
+30.15%
1-year return
+139.18%
Avg volume
46.15K
Previous close
11.05
52-week range
2.88 – 18.20

 

No chart data for this range yet.

Key statistics

Enterprise value
5.46M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
0
Total cash
23.00K
Total debt
151.00K
Return on equity
0.00%
Short % of float
0.00%
50-day average
1.17
200-day average
1.17

Fundamental scorecard

6 of 25 checks passed on PLRZ’s reported financials

ValueGrowthProfitabilityHealthDividend

6of 25 checks passed

  • Value 0 of 5
  • Growth 1 of 5
  • Profitability 0 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Financials — quick view

All financials
PLRZ Revenue — annual 0
PLRZ Net income — annual -3.33M
PLRZ EPS — annual -4.90

About Polyrizon Ltd.

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a containment barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Sector
Healthcare
Industry
Biotechnology
Country
Israel

News

Your note

Sign in to keep a note on PLRZ — it syncs with the Stock Master app.